Delivery Order SPE2DB24D9241-SPE2DB25FHGLU
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,811.55 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. The contract, issued on June 16, 2025, with an ultimate completion date of July 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,041.56 by the Defense Logistics Agency (DLA) on September 25, 2025, for Mirena 52 mg systems. The award is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. The contract, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. This award represents a direct delivery under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $12.5K by the Defense Logistics Agency (DLA) on July 25, 2025, for Mirena 52 mg systems with an ultimate completion date of August 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Mirena 52 mg systems, with a ceiling value of $1,041.56. The award, issued on August 6, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 27, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $26,038.50 by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Mirena 52 mg systems. The delivery order carries an ultimate completion date of October 17, 2025, and represents no set-aside designation. This award is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,623.10 by the Defense Logistics Agency (DLA) on August 15, 2025, for Mirena 52 mg systems. The award carries an ultimate completion date of September 8, 2025, and includes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,207.70 by the Defense Logistics Agency for Mirena 52 mg systems. The contract, awarded on September 15, 2025, with an ultimate completion date of October 6, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a task order under the company's larger single-award Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through...
- SPE2DB24D9241Indefinite Delivery Contract
- SPE2DB24D9241-SPE2DB25FHGLUDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,041.56 by the Defense Logistics Agency (DLA) on August 26, 2025, for Mirena 52 mg systems. The award is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million and valid through November 2026. The Mirena system is a hormone-releasing intrauterine device used for contraception and gynecological applications. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group regularly fulfills delivery orders for the DLA to support medical supply needs at Department of Defense healthcare facilities worldwide. The company's extensive contract portfolio with the DLA demonstrates its established capability to deliver a comprehensive range of pharmaceutical products, including prescription medications, biologics, medical consumables, and specialized devices to military health facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/26/25 |